3 months compounded semaglutide (GLP-1) Compounded Semaglutide Injection Three Month

Fetissov SO, Meguid MM

Dehydration risk increases in seniors taking semaglutide because nausea can occur during dose escalation, potentially reducing fluid intake at a time when older adults already drink less water

The FDA has received reports of adverse events, including hospitalizations, associated with compounded injectable semaglutide tied to dosing errors

[1] [2] Flatulence and eructation (burping) are specifically listed as common side effects

During Ozempic clinical trials, 20% of participants experienced nausea, and 10% noted occurrences of vomiting, which are both symptoms prevalent in cases of gastroparesis

Practical application: 4 sessions per week of 10 to 15 minutes each, ideally immediately after RF treatment when skin is most receptive